LARIMAR THERAPEUTICS
6,9450
08-октября-24 12:32:09
15 мин. задержка
Акции
+0,4650
+7,18%
Сегодняшний диапазон
6,4500 - 6,9535
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
15 май 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Days
28 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results
14 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer
07 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the 34th Annual Piper Sandler Healthcare Conference
21 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
10 ноя 2022 07:00:04 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in the Guggenheim 4th Annual Immunology & Neurology Day
07 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
20 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
19 окт 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
16 сен 2022 13:00:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces $70 Million Underwritten Offering
14 сен 2022 07:04:00 Источник Nasdaq GlobeNewswire
-
14 сен 2022 07:01:00 Источник Nasdaq GlobeNewswire
-
11 авг 2022 16:05:03 Источник Nasdaq GlobeNewswire
-
28 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
28 июн 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Upcoming Scientific Conference Presentations
02 июн 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
19 май 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
12 май 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
25 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
14 фев 2022 16:01:00 Источник Nasdaq GlobeNewswire